Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
The mpox emergency declaration ended at the end of January 2023.News Article updated on 02/02/2023
-
RWHAP Part A Guidance for Planning Bodies on Supporting People with Lived Experience
From the HRSA HIV/AIDS Bureau Listserv, 12/16/22
News Article updated on 12/19/2022 -
RWHAP Program Letter: ADAPs and SUD Medications
On May 11, HRSA’s HIV/AIDS Bureau released a program letter encouraging RWHAP ADAP recipients to include medications for SUDs, including buprenorphine for OUD, and naloxone for opioid overdose prevention, on ADAP formularies.News Article updated on 05/15/2023 -
STI Implementation Plan Released
HHS has released an implementation plan on specific actions for entities to take in preventing and treating sexually transmitted infections (STI).News Article updated on 06/13/2023 -
HAB EHE Initiative Year 2 Qualitative Summary Report
HRSA HAB is pleased to release the HRSA HIV/AIDS Bureau Ending the HIV Epidemic in the U.S. (EHE) Initiative Qualitative Summary of Progress: March 2021-February 2022.News Article updated on 10/19/2023 -
Ryan White and World AIDS Day 2023
December 1 is World AIDS Day. The 2023 theme is World AIDS Day 35: Remember and Commit.Blog updated 03/28/2024
-
A Selection of Community Engagement Tools
Access these National Academy of Medicine and RWHAP consumer engagement tools.News Article updated on 06/23/2023 -
Coming Up: Implementation Resources from Black Women First Initiative
Black Women First works to close gaps in equity of care and health disparities for Black Cisgender and Transgender women living with HIV.News Article updated on 01/26/2024 -
New Training Modules on Creating an HIV/HCV Viral Clearance Cascade
Training modules are now available on how to use public health surveillance data, along with clinical data, to track efforts in getting people co-infected with HIV and hepatitis C engaged in care and on effective treatment.News Article updated on 02/05/2024 -
HRSA HAB on National Black HIV/AIDS Awareness Day
HRSA HIV/AIDS Bureau Update: Special Bulletin - Dear Ryan White HIV/AIDS Program Colleagues,
News Article updated on 02/07/2024 -
National HIV PrEP Curriculum Released
Pretty much everything a health professional would need or want to know about HIV PrEP is available on the just-released National HIV PrEP Curriculum.News Article updated on 02/12/2024 -
Input Sought on Federal HIV Research Priorities
The NIH Office of AIDS Research (OAR) leads the effort across NIH to establish HIV research priorities and develop the NIH Strategic Plan for HIV and HIV-Related Research.News Article updated on 02/15/2024 -
Ryan White, Aging and HIV
HRSA has devoted increased attention to addressing the needs of older individuals with HIV with guidances, intervention ideas, and a new aging and HIV initiative.
Blog updated 03/29/2024
-
Ryan White and World AIDS Day 2022
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
-
Ryan White HIV Care and Gay/Bisexual Men
Learn about Ryan White HIV care innovations targeted to gay/bisexual men, who comprise nearly half of the program's clients.
Blog updated 03/29/2024
-
Ryan White HIV Care and Latinos
Learn about the Ryan White HIV/AIDS Program's commitment to HIV/AIDS care among Latino populations.
Blog updated 03/29/2024
-
Ryan White HIV Care and Asian Pacific Islanders
Asians and Native Hawaiian/Pacific Islanders each comprised less than 2% of Ryan White HIV/AIDS Program (RWHAP) clients.
Blog updated 05/24/2024
-
Ryan White HIV Care and Youth
The Ryan White HIV/AIDS Program has a rich history as an delivering HIV care to young people, especially hard-to-reach populations.
Blog updated 05/06/2024
-
Ryan White and Hepatitis/HIV Care
Access these tools on integrating hepatitis screening and treatment within HIV care programs.
Blog updated 05/29/2024
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024